A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1
for HIV Infections
41 locations incl. Birmingham
Sponsor: ViiV Healthcare
Sex: All·Age: 12+
Code: NCT06694805·Phase 3·Recruiting